Filing Details

Accession Number:
0001415889-25-003418
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-07 21:35:09
Reporting Period:
2025-02-05
Filing Date:
2025-02-07
Accepted Time:
2025-02-07 21:35:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2010019 Solomon Moshkevich C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
President, Clinicaldiagnostics No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-02-05 1,675 $0.00 149,878 No 4 A Direct
Common Stock Acquisiton 2025-02-05 1,522 $0.00 151,400 No 4 A Direct
Common Stock Disposition 2025-02-06 1,632 $177.77 149,768 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 S Direct
Footnotes
  1. On October 22, 2021, the Reporting Person was granted Restricted Stock Units ("RSUs") covering 10,000 shares of Common Stock which vest in tranches upon the achievement of certain milestones relating to a combination of the passage of time and certain business performance criteria. On February 5, 2025, the achievement of criteria was certified for the vesting of RSUs covering 1,675 shares of Common Stock.
  2. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  3. On January 28, 2022, the Reporting Person was granted RSUs covering 6,087 shares of Common Stock which vest upon the achievement of certain milestones relating to a combination of the passage of time and certain business performance criteria. On February 5, 2025, the achievement of criteria was certified for the vesting of RSUs covering 1,522 shares of Common Stock.
  4. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on October 22, 2021 and January 28, 2022, respectively.